DOW Stock Analysis: Dow | NYSE
Chemicals | NYSE, USA | Market Cap: 22.320m USD | 12M Return: 36.9% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 306M
Qual. Beats: 3
Rev. Trend: -94.3%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 7.3 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Dow Inc. is a U.S.-headquartered materials science company that provides chemical products and solutions across packaging, infrastructure, mobility, and consumer end-markets. The company operates globally with a presence in North America, Europe, the Middle East, Africa, India, Asia Pacific, and Latin America, and runs three core reporting segments: Packaging & Specialty Plastics (ethylene, propylene, polyethylene, aromatics, and related derivatives), Industrial Intermediates & Infrastructure (polyurethanes, chlor-alkali and vinyl products, and construction chemicals), and Performance Materials & Coatings (architectural and industrial coatings, acrylics, silicon metals, and siloxanes). In addition to its chemicals operations, Dow also maintains a property and casualty insurance and reinsurance business. Founded in 1897 and based in Midland, Michigan, Dow began trading on the NYSE under the ticker DOW following its March 2019 spin-off from DowDuPont.
As a large-cap company classified within the GICS Materials sector and Commodity Chemicals sub-industry, Dow operates in a cyclical, capital-intensive industry where margins are closely tied to feedstock costs, energy prices, and global industrial demand. Its vertically integrated business model spans basic petrochemicals (olefins and aromatics) up through higher-value performance products, allowing it to serve both commodity-grade and specialty end uses.
- Polyethylene oversupply pressures Packaging & Specialty Plastics margins
- European energy costs squeeze polyurethane and chlor-alkali spreads
- Dividend and buyback program anchors total shareholder returns
| Net Income: -2.76b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.02 > 0.02 and ΔFCF/TA -1.47 > 1.0 |
| NWC/Revenue: 22.71% < 20% (prev 13.47%; Δ 9.24% < -1%) |
| CFO/TA 0.05 > 3% & CFO 2.81b > Net Income -2.76b |
| Net Debt (17.0b) to EBITDA (840.0m): 20.25 < 3 |
| Current Ratio: 1.85 > 1.5 & < 3 |
| Outstanding Shares: last quarter (721.2m) vs 12m ago 2.02% < -2% |
| Gross Margin: 6.16% > 18% (prev 8.91%; Δ -2.75% > 0.5%) |
| Asset Turnover: 67.07% > 50% (prev 74.14%; Δ -7.07% > 0%) |
| Interest Coverage Ratio: -1.51 > 6 (EBIT TTM -1.33b / Interest Expense TTM 881.0m) |
| A: 0.15 (Total Current Assets 19.5b - Total Current Liabilities 10.5b) / Total Assets 59.8b |
| B: 0.27 (Retained Earnings 16.0b / Total Assets 59.8b) |
| C: -0.02 (EBIT TTM -1.33b / Avg Total Assets 58.6b) |
| D: 0.35 (Book Value of Equity 15.2b / Total Liabilities 43.0b) |
| Altman-Z'' = 2.07 = BBB |
| DSRI: 1.12 (Receivables 7.41b/7.18b, Revenue 39.3b/42.6b) |
| GMI: 1.45 (GM 8.91% / 6.16%) |
| AQI: 1.00 (AQ_t 0.30 / AQ_t-1 0.30) |
| SGI: 0.92 (Revenue 39.3b / 42.6b) |
| TATA: -0.09 (NI -2.76b - CFO 2.81b) / TA 59.8b) |
| Beneish M = -2.59 (Cap -4..+1) = A |
As of August 02, 2026, the stock is trading at USD 30.29 with a total of 6,367,006 shares traded. Over the past week, the price has changed by +1.51%, over one month by +10.71%, over three months by -24.43% and over the past year by +36.86%.
Current recommended Stop Loss: 27.80 (which is 8.2% or 2 ATR below the current price).
Dow has received a consensus analysts rating of 3.33. Therefore, it is recommended to hold DOW.
- StrongBuy: 4
- Buy: 0
- Hold: 16
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 36.6 | 20.7% |
P/E Forward = 10.627
P/S = 0.5675
P/B = 1.477
P/EG = 38.8911
Revenue TTM = 39.3b USD
EBIT TTM = -1.33b USD
EBITDA TTM = 840.0m USD
Long Term Debt = 17.3b USD (from longTermDebt, last quarter)
Short Term Debt = 1.23b USD (from shortTermDebt, last quarter)
Debt = 21.1b USD (from shortLongTermDebtTotal, last quarter) + Leases 1.49b
Net Debt = 17.0b USD (calculated: Debt 21.1b - CCE 4.11b)
Enterprise Value = 39.3b USD (22.3b + Debt 21.1b - CCE 4.11b)
Interest Coverage Ratio = -1.51 (Ebit TTM -1.33b / Interest Expense TTM 881.0m)
EV/FCF = -28.20x (Enterprise Value 39.3b / FCF TTM -1.40b)
FCF Yield = -3.55% (FCF TTM -1.40b / Enterprise Value 39.3b)
FCF Margin = -3.55% (FCF TTM -1.40b / Revenue TTM 39.3b)
Net Margin = -7.02% (Net Income TTM -2.76b / Revenue TTM 39.3b)
Gross Margin = 6.16% ((Revenue TTM 39.3b - Cost of Revenue TTM 36.9b) / Revenue TTM)
Gross Margin QoQ = 6.53% (prev 5.79%)
Tobins Q-Ratio = 0.66 (Enterprise Value 39.3b / Total Assets 59.8b)
Interest Expense / Debt = 4.17% (Interest Expense 881.0m / Debt 21.1b)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -1.05b (EBIT -1.33b * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.85 (Total Current Assets 19.5b / Total Current Liabilities 10.5b)
Debt / Equity = 1.39 (Debt 21.1b / totalStockholderEquity, last quarter 15.2b)
Debt / EBITDA = 20.25 (Net Debt 17.0b / EBITDA 840.0m)
Debt / FCF = -12.20 (negative FCF - burning cash) (Net Debt 17.0b / FCF TTM -1.40b)
Total Stockholder Equity = 16.5b (last 4 quarters mean from totalStockholderEquity)
RoA = -4.71% (Net Income -2.76b / Total Assets 59.8b)
RoE = -16.73% (Net Income TTM -2.76b / Total Stockholder Equity 16.5b)
RoCE = -3.93% (EBIT -1.33b / Capital Employed (Equity 16.5b + L.T.Debt 17.3b))
RoIC = -2.16% (negative operating profit) (NOPAT -1.05b / Invested Capital 48.5b)
WACC = 6.05% (E(22.3b)/V(43.4b) * Re(8.66%) + D(21.1b)/V(43.4b) * Rd(4.17%) * (1-Tc(0.21)))
Discount Rate = 8.66% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 84.25 | Cagr: 1.10%
[DCF] Fair Price = unknown (Cash Flow -1.40b)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 1.06 | # QB: 3
Revenue Correlation: -94.34 | Revenue CAGR: -6.17% | SUE: 0.83 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.84 | Chg30d=-30.09% | Revisions=+0% | Analysts=13
EPS current Year (2026-12-31): EPS=2.55 | Chg30d=-15.07% | Revisions=-10% | GrowthEPS=+370.8% | GrowthRev=+9.4%
EPS next Year (2027-12-31): EPS=1.85 | Chg30d=-14.65% | Revisions=+0% | GrowthEPS=-27.2% | GrowthRev=+1.3%
[Analyst] Revisions Ratio: -6% (up=7, down=8)